Results 251 to 260 of about 568,428 (265)

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Lancet, The, 2023
exaly  

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

Lancet, The, 2012
Robert P Giugliano, Payal Kohli, Marc S Sabatine   +2 more
exaly  

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Lancet, The, 2023
exaly  

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Lancet, The, 2010
Richard M Bergenstal, Carol H Wysham
exaly  

Investigation of a Baldwin SR-4 type N portable strain indicator for determination of its intrinsic safety for coal mine use

1958
openaire   +1 more source

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Lancet, The, 2012
Baptist Gallwitz
exaly  

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

Lancet, The, 2023
exaly  

Surgical therapy of hepatic colorectal metastasis

Ca-A Cancer Journal for Clinicians, 1999
Yuman Fong
exaly  

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

New England Journal of Medicine, 2017
Steven P Marso, Darren K Mcguire, Bernard Zinman Cm   +2 more
exaly  

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
Itamar Raz, Marc P Bonaca, Ofri Mosenzon
exaly